Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)

NCT02558972 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Could not recruit adequate numbers. Largely closed by COVID risk.

Conditions

Postural Tachycardia Syndrome (POTS)
Vasovagal Syncope (VVS)
Fainting

Interventions

DRUG: Northera (Droxidopa)
DRUG: Placebo
DRUG: Northera (Droxidopa)
DRUG: Placebo

Sponsor

New York Medical College

Collaborators

[object Object]